NCM
CERE

Nantahala Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Nantahala Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-685,704
Closed -$11.4M – 125
2020
Q4 		$11.4M Buy
+685,704
New +$11.4M 0.35% 51